RxSight

Forecast & Rating10 analysts currently cover RxSight, with about 10.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $7.79, about 24.4% upside from the current price of $6.26. Price targets range from $6.00 to $11.00 — a wide spread, showing clear disagreement over just how much RxSight can rise. Historically, about 71.0% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on RxSight's outlook. Data as of Aug 10, 2026; for reference only and not investment advice.